PLEURAL MESOTHELIOMA - CLINICAL FEATURES AND THERAPEUTIC IMPLICATIONS

被引：137

作者：

LEGHA, SS ^{[1
]}

MUGGIA, FM ^{[1
]}

机构：

[1] NCI, DIV CANC TREATMENT, PROGRAM CANC THERAPY EVALUAT, BETHESDA, MD 20014 USA

来源：

关键词：

D O I：

10.7326/0003-4819-87-5-613

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：613 / 621

页数：9

共 98 条

[21] ESCHWEGE F, 1973, J RADIOL ELEC MED N, V54, P255
[22] FISHER ER, 1960, CANCER, V13, P837, DOI 10.1002/1097-0142(196007/08)13:4<837::AID-CNCR2820130428>3.0.CO
[23] 2-4
[24] CHEMOTHERAPY OF MALIGNANT MESOTHELIOMA
GERNER, RE
MOORE, GE
[J]. ONCOLOGY, 1974, 30 (02) : 152 - 155
[25] GOTTLIEB JA, 1974, P AM ASSOC CANC RES, V15, P162
[26] GOTTLIEB JA, 1972, CANCER-AM CANCER SOC, V30, P1632, DOI 10.1002/1097-0142(197212)30:6<1632::AID-CNCR2820300632>3.0.CO
[27] 2-S
[28] DIFFUSE PLEURAL MESOTHELIOMA - A SURVIVAL OF ONE YEAR FOLLOWING NITROGEN MUSTARD THERAPY
GRAY, FW
TOM, BCK
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1962, 44 (01) : 73 - &
[29] GREENBERG M, 1974, BRIT J IND MED, V31, P91
[30] HARINGTON JS, 1963, BRIT J EXP PATHOL, V44, P81